FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1231-1233 April 28, 1994 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The Epstein-Barr virus (EBV), a ubiquitous herpesvirus estimated to infect 90 percent of the world's population,¹ has been linked to a growing number of diseases, especially in immunocompromised hosts. The first ties between neoplastic disease and EBV were discovered in Burkitt's lymphoma² and nasopharyngeal carcinoma. The virus has also been found in immunoblastic lymphomas in allograft recipients and persons infected with the human immunodeficiency virus (HIV),³ and in the oral hairy leukoplakia of AIDS. Recently, the EBV genome has been detected in Reed-Sternberg cells in some cases of Hodgkin's disease⁴ and in KI-1+ lymphoma, various T-cell lymphomas, thymic carcinoma, and . . . [Full Text of this Article]

References

This article has been cited by other articles:

• KASISKE, B. L., VAZQUEZ, M. A., HARMON, W. E., BROWN, R. S., DANOVITCH, G. M., GASTON, R. S., ROTH, D., SCANDLING, J. D. JR., SINGER, G. G. (2000). Recommendations for the Outpatient Surveillance of Renal Transplant Recipients. J. Am. Soc. Nephrol. 11 : S1-S86 [Abstract] [Full Text]  
• Deeg, H. J., Socie, G. (1998). Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers. Blood 91: 1833-1844 [Full Text]